Raffa Wealth Management’s NovoCure NVCR Stock Holding History

Raffa Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242	Hold	16	–	–	﹤0.01%	1241
2026 Q1	$174	Hold	16	–	–	﹤0.01%	1200
2025 Q4	$207	Hold	16	–	–	﹤0.01%	1131
2025 Q3	$207	Hold	16	–	–	﹤0.01%	1145
2025 Q2	$285	Hold	16	–	–	﹤0.01%	1053
2025 Q1	$285	Hold	16	–	–	﹤0.01%	1023
2024 Q4	$477	Hold	16	–	–	﹤0.01%	1009
2024 Q3	$250	Hold	16	–	–	﹤0.01%	1045
2024 Q2	$274	Hold	16	–	–	﹤0.01%	1107
2024 Q1	$250	Hold	16	–	–	﹤0.01%	1092
2023 Q4	$239	Hold	16	–	–	﹤0.01%	1027
2023 Q3	$258	Hold	16	–	–	﹤0.01%	1012
2023 Q2	$664	Hold	16	–	–	﹤0.01%	907
2023 Q1	$962	Hold	16	–	–	﹤0.01%	803
2022 Q4	$1.17K	Hold	16	–	–	﹤0.01%	732
2022 Q3	$1.22K	Hold	16	–	–	﹤0.01%	734
2022 Q2	$1.11K	Hold	16	–	–	﹤0.01%	781
2022 Q1	$1.33K	Hold	16	–	–	﹤0.01%	760
2021 Q4	$1.2K	Sell	16 -4	-20%	-$402	﹤0.01%	811
2021 Q3	$2.32K	Hold	20	–	–	﹤0.01%	577
2021 Q2	$4.44K	Hold	20	–	–	﹤0.01%	408
2021 Q1	$2.64K	Buy	20 +16	+400%	+$2.53K	﹤0.01%	561
2020 Q4	$692	Buy	+4	New	+$547	﹤0.01%	813
2020 Q2	–	Sell	-6	Closed	-$404	–	895
2020 Q1	$404	Buy	+6	New	+$474	﹤0.01%	781

Other funds holding NVCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Raffa Wealth Management's NVCR Position: Q2 2026 in Review

Raffa Wealth Management held its NovoCure (NVCR) position steady in Q2 2026 at 16 shares worth $242. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Raffa Wealth Management first reported a position in NVCR in Q1 2020 and has held it in 24 quarters since. The position peaked at $4.44K in Q2 2021. 199 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Raffa Wealth Management held 16 shares of NovoCure worth $242 as of Q2 2026.
Raffa Wealth Management left its NovoCure share count unchanged in Q2 2026.
NovoCure made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1241 holding.
Raffa Wealth Management first reported a position in NovoCure in Q1 2020 and has held it in 24 quarters since.
Raffa Wealth Management's NovoCure position peaked at $4.44K in Q2 2021.
199 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.